Abstract:Objective: Urinary N-acetyl-β-glucosaminidase(NAGase) and Retinal-binding protein(RBP) has been applied as sensitive clinical markers of acute tubulointerstial damage s. Further study is in need to evaluate their relevance with pathological change s and clinical functional changes in different entities of tubulointerstitial di sorders and glomerular diseases. In this study, we explored the relevance of the se markers with the tubulointerstitial lesion and glomerular function in classic al tubulointerstitial disorders as chronic aristolochic acid nephropathy (CAAN) and Sjogren syndrome related nephropathy (SSN), and in glomerulonephropathy as I gA nephropathy (IgAN) and lupus nephropathy (LN). Methodology:This study included 9 patients with SSN, 14 patients with CAAN, 169 patients wit h IgAN and 83 patients with type-Ⅳ or type-Ⅴ LN. All patients were hospitali zed for evaluation, and underwent a renal biopsy. Urinary RBP and NAGase were de termined with ELISA and colourimetric assay respectively. Other laboratory tests including urinary C3, urinary α 2M, 24 hour urinary protein excetion, and ser um creatinine (SCr) were studied. Histological changes of renal biopsy slides we re reviewed and graded semi-quantitatively according to the extent of tubulointe rstitial lesion. Changes of urinary RBP and NAG and their relationship with tubu lar interstitial damage were analyzed, with respect to the four different groups of patients. Influencing factors on urinary RBP and NAG were explored. Results:In patients with Sjogren's disease, CAAN, IgAN and LN, the percentages of patien ts with increased urine RBP and NAG were 100% and 88.89%、85.71% and 71.43 %、37.28% and 56.21%,69.88% and 97.59%, respectively. RBP and NAG excr etion increased while tubular-interstitial lesion deteriorate. In SSN and CAAN, The urinary excretion of RBP and NAG had no significant co-relationship with th at of urinary C3 and α 2M (P0.05). There is no significant change of uri nary RBP and NAG when SCr increase (P0.05). In IgAN, The excretion of RBP had significant co-relationship with that of urinary C3(P0.01), the exc retion of NAG had significant co-relationship with that of urinary C3 and α 2 M(P0.01). RBP and NAG excretion increased while 24h urine protein excret ion or SCr raised. In LN, The excretion of RBP and NAG had significant co-relat ionship with that of urinary C3 and α 2M respectively(P0.01). The excr etion of NAG increased when 24h urine protein aggrandized(P0.05)and that of RBP increased along with SCr. Conclusion:Examinations of urine RBP and NAG are effective methods for assessing renal tubu lar interstitial lesion. Urine RBP and NAG levels correlate with tubular interst itial historical change and show various characters in different nephropathies. In patients characterized by tubulointerstitial lesion, such as SSN and CAAN, ur inary RBP and urinary NAG correlated well with the extent of tubulointerstitial changes. In patients characterized by glomerular lesion and accompanied tubuloin terstitial changes, the extent of using RBP and urinary NAG are influenced by fa ctors including 24-hour urinary protein excretion, urinary protein selectivity, and serum levels of creatinine.

Urinary Mrna Expression of CCN2/CCN3 As a Noninvasive Marker for Monitoring Glomerular Structure Changes in Nondiabetic Chronic Kidney Disease

Urinary C-X-C Motif Chemokines 13 is a Noninvasive Biomarker of Antibody-Mediated Renal Allograft Rejection

Bioinformatics analysis reveals CCR7 as a potential biomarker for predicting CKD progression

Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma

Clinical Significance of Determination of Serum Cystatin C,lipoprotein (α) and High Sensitivity C-reactive Protein in Type 2 Diabetic Patients with Early Renal Impairment.

The urinary RNA atlas of patients with chronic kidney disease

[Urinary Connective Tissue Growth Factor As a Biomarker Chronic Allograft Nephropathy in a Rat Model].

Angiopoietin-like Protein 3: a Novel Potential Biomarker for Nephrotic Syndrome in Children

Bcl-3 is a Novel Biomarker of Renal Fibrosis in Chronic Kidney Disease

A Novel Biomarker in Differentiating MCN and MN: Urinary sCD80

Evaluating new biomarkers for diabetic nephropathy: Role of α2-macroglobulin, podocalyxin, α-L-fucosidase, retinol-binding protein-4, and cystatin C

Urinary exosomes derived circRNAs as biomarkers for chronic renal fibrosis

mRNA Levels and Immunofluorescence Staining for Various Markers

Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma.

Integrative analysis of deoxyribonuclease 1-like 3 as a potential biomarker in renal cell carcinoma

Bioinformatic Analysis and Clinical Case Studies Identify CD276 as a Promising Diagnostic Biomarker for Clear Cell Renal Cell Carcinoma

Clinical Application of the Urinary Markers of Renal Tubular Injury

Exploring diagnostic biomarkers of type 2 cardio-renal syndrome based on secreted proteins and bioinformatics analysis

Validation of prognostic signature and exploring the immune-related mechanisms for NR3C2 in clear cell renal cell carcinoma

Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function

Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathological Kidney Tissue Alterations in Patients with IgA Nephropathy